Composition BPC-157: 10 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment via HPLC/LC-MS Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available (HPLC/LC-MS) Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Manufactured in the USA in an ISO 9001based, cGMP-aligned facility Lot-specific COA (HPLC/LC-MS) with verification key Third-party verification link provided per lot (Janoshik) Lyophilized for transit stability
doi: 10.2147/IDR.S256773 169 LinaniA.BenarousK.Bou-SalahL.YousfiM.Goumri-SaidS
Treatment for MCL injuries typically involves rest, ice, compression, elevation (RICE), physical therapy, and in severe cases, surgical intervention
Product Specifications Strength: 0.5mg per 30mL solution Format: Nasal liquid solution Packaging: 30mL vial with secure closure Storage and Handling: Store under recommended laboratory conditions to maintain peptide integrity
Always wear sterile gloves, work on a clean, disinfected surface, and use sterile equipment
GHK-Cu is 100% natural and improves DNA repair process